Alzheimer's disease
Amyloid and Tau PET imaging advance Alzheimer's disease diagnosis
Molecular imaging allows clinicians to visualize amyloid-β plaques and tau tangles in living patients, shifting Alzheimer's diagnosis toward a biological model.
WHO: Up To 45% Dementia Risk Can Be Prevented Or Delayed
New WHO guidelines provide evidence-based recommendations to protect cognitive health by addressing modifiable risk factors such as air pollution and diet.
Damaged myelin generates abnormal rhythms in the sleeping brain
A new study reveals how the degeneration of the myelin sheath disrupts brain oscillations and rhythms during sleep, potentially providing non-invasive biomarkers for neurodegenerative diseases.
Does fish oil reduce Alzheimer’s risk? What a new US study says
Research suggests that people with high-risk gene variants derive the most substantial cognitive protection from omega-3s and Mediterranean-style eating patterns.
Lecanemab for Alzheimer's shows cognitive benefit despite serious risks
Lecanemab has demonstrated a statistically significant ability to reduce cognitive decline in early Alzheimer's patients, despite serious safety risks and high costs.
US dementia death rates remain above pre-pandemic levels through 2022
Data from the National Center for Health Statistics shows dementia death rates have not yet returned to 2019 levels, highlighting significant gender and racial disparities.
US dementia costs reach $818 billion, exceeding cancer and heart disease
A new study reveals the staggering economic burden of Alzheimer's and related dementias, with costs projected to reach nearly $1 trillion by 2050.